Showing results (511-520 of 1,681) with videos related to
Sort By:
Pageof 169
Seminars in Hematology|October 1, 1993
Vaccinia virus: a novel approach for molecular engineering of peptide vaccinesD E HrubySeminars in Hematology|April 1, 1993
Prediction and management of adverse events associated with the use of factor IX complex concentratesJ M LusherSeminars in Hematology|October 1, 1995
Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamineP J Giardina, R W GradySeminars in Hematology|October 1, 1996
A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemiaT Masaoka, M Ogawa, K Yamada, et al.Seminars in Hematology|October 1, 1996
Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter studyH S Park, D W Kim, C C Kim, et al.Seminars in Hematology|January 1, 1997
The role of autologous hematopoietic stem cell transplantation in multiple myelomaJ L Harousseau, M AttalSeminars in Hematology|January 15, 2011
Myelomagenesis: capturing early microenvironment changesNeha Korde, Irina MaricSeminars in Hematology|January 15, 2011
Role of flow cytometry of peripheral blood and bone marrow aspirates in early myelomaConstance M Yuan, Maryalice Stetler-StevensonSeminars in Hematology|April 1, 1990
Adverse events reported in association with the use of monoclonal antibody purified factor VIIIC--MonoclateD C BrownSeminars in Hematology|April 1, 1990
Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIICK J Smith, J M Lusher, A R Cohen, et al.Pageof 169